Literature DB >> 10076170

Vasomotor flushes in menopausal women.

G A Bachmann1.   

Abstract

Vasomotor symptoms after menopause are multifactorial in origin but result primarily from the loss of estrogen as ovarian function ceases. Although hot flushes typically last for 0.5 to 5.0 years after natural menopause, they may persist for as long as 15 years in a small percentage of postmenopausal women. In contrast, hot flushes tend to last longer and be more severe in surgically menopausal women. One of the major complaints associated with vasomotor symptoms is insomnia, which can have a domino effect on the patient's overall quality of life. Conventional hormone replacement therapy is effective in controlling vasomotor symptoms, including insomnia, for most postmenopausal women. However, data suggest that estrogen-androgen replacement therapy provides additional relief for women with persistent or severe vasomotor symptoms, especially women scheduled to undergo surgical menopause.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076170     DOI: 10.1016/s0002-9378(99)70725-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  33 in total

1.  Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms.

Authors:  Verne E Cowles; Toufigh Gordi; Sui Yuen Eddie Hou
Journal:  Clin Drug Investig       Date:  2012-09-01       Impact factor: 2.859

2.  Nitric oxide synthase inhibition attenuates cutaneous vasodilation during postmenopausal hot flash episodes.

Authors:  Kimberly A Hubing; Jonathan E Wingo; R Matthew Brothers; Juan Del Coso; David A Low; Craig G Crandall
Journal:  Menopause       Date:  2010 Sep-Oct       Impact factor: 2.953

Review 3.  Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.

Authors:  Rodney Baber; Martha Hickey; Michelle Kwik
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.

Authors:  Nancy E Avis; Sybil L Crawford; Robin Green
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

5.  Brain blood flow and cardiovascular responses to hot flashes in postmenopausal women.

Authors:  Rebekah A I Lucas; Matthew S Ganio; James Pearson; Craig G Crandall
Journal:  Menopause       Date:  2013-03       Impact factor: 2.953

6.  Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants.

Authors:  Yali A Bair; Ellen B Gold; Gail A Greendale; Barbara Sternfeld; Shelley R Adler; Rahman Azari; Martha Harkey
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

Review 7.  Estradiol valerate/dienogest.

Authors:  Keri Wellington; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Acupuncture for treating hot flashes in breast cancer patients: an updated meta-analysis.

Authors:  Alireza Salehi; Maryam Marzban; Abbas Rezian Zadeh
Journal:  Support Care Cancer       Date:  2016-08-06       Impact factor: 3.603

9.  A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.

Authors:  T G Tzellos; G Papazisis; K A Toulis; Ch Sardeli; D Kouvelas
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

Review 10.  Breast cancer in young women and its impact on reproductive function.

Authors:  M Hickey; M Peate; C M Saunders; M Friedlander
Journal:  Hum Reprod Update       Date:  2009-01-27       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.